All In Biotech

Drug Trial Radar · NCT03766581

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

A Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of BMS-986177, an Oral Factor XIa Inhibitor, for the Prevention of New Ischemic Stroke or New Covert Brain Infarction in Patients Receiving Aspirin and Clopidogrel Following Acute Ischemic Stroke or Transient Ischemic Attack (TIA)

Last checked: Nov 20, 2026Latest source record: Jun 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 2,366 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,366

Actual

Start

Jan 27, 2019

Primary completion

Mar 31, 2022

Study completion Mar 31, 2022

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
Collaborators
Janssen, LP
First posted
Dec 6, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to determine whether the addition of an oral Factor XIa Inhibitor to Aspirin and Clopidogrel is more effective than standard therapy in secondary stroke prevention.

Conditions

  • Acute Ischemic Stroke
  • Transient Ischemic Attack (TIA)

Interventions

  • BMS-986177Drug

    Oral administration

  • PlaceboOther

    Oral Administration

  • ClopidogrelDrug

    Oral administration

  • AspirinDrug

    Oral administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Participants With Model Based Assessment of Composite of New Ischemic Stroke During Treatment and New Covert Brain Infarction (FLAIR + DWI) Detected by MRI by Day 90Time frame: From randomization to up to 90 days after randomization

Locations

424 sites in 29 countries. Site status is shown where the registry gives one.

  • Local Institution - 0029

    Birmingham, Alabama

  • Local Institution - 0007

    Glendale, California

  • Local Institution - 0006

    Long Beach, California

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California

  • Local Institution - 0231

    Los Angeles, California

  • Local Institution - 0376

    Sacramento, California

  • Local Institution - 0004

    Stanford, California

  • Local Institution - 0042

    Torrance, California

  • Local Institution - 0340

    Newark, Delaware

  • Local Institution - 0075

    Gainesville, Florida

  • Local Institution - 0013

    Sarasota, Florida

  • Local Institution - 0024

    Tampa, Florida

  • Local Institution - 0015

    Augusta, Georgia

  • Local Institution - 0428

    Honolulu, Hawaii

  • Local Institution - 0293

    Chicago, Illinois

  • University of Illinois Hospital & Health Sciences System

    Chicago, Illinois

  • Local Institution - 0430

    Elk Grove Village, Illinois

  • Local Institution - 0382

    Rockford, Illinois

  • Local Institution - 0346

    Louisville, Kentucky

  • Local Institution - 0047

    New Orleans, Louisiana

  • Local Institution - 0420

    Baltimore, Maryland

  • Local Institution

    Boston, Massachusetts

  • Local Institution - 0236

    Boston, Massachusetts

  • Local Institution

    Detroit, Michigan

  • Local Institution - 0434

    Detroit, Michigan

  • Local Institution

    Detroit, Michigan

  • Local Institution - 0375

    Farmington Hills, Michigan

  • Local Institution

    Minneapolis, Minnesota

  • Local Institution

    Kansas City, Missouri

  • Local Institution

    St Louis, Missouri

  • Local Institution - 0294

    St Louis, Missouri

  • Local Institution - 0352

    St Louis, Missouri

  • Advanced Neurology Specialists PLLC

    Great Falls, Montana

  • Local Institution - 0276

    Camden, New Jersey

  • Local Institution - 0039

    New Brunswick, New Jersey

  • Local Institution - 0354

    Brooklyn, New York

  • Local Institution

    Buffalo, New York

  • Local Institution

    New York, New York

  • Local Institution - 0125

    New York, New York

  • Duke University Medical Center

    Butner, North Carolina

Showing 40 of 424 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.